Molecular basis of maillard amide-advanced glycation end product (AGE) formation in vivo
about
Comprehensive analysis of maillard protein modifications in human lenses: effect of age and cataractExtending the spectrum of α-dicarbonyl compounds in vivo.Association of plasma levels of soluble receptor for advanced glycation end products and risk of kidney disease: the Atherosclerosis Risk in Communities studyN-lactoyl-amino acids are ubiquitous metabolites that originate from CNDP2-mediated reverse proteolysis of lactate and amino acids.Marked increase in rat red blood cell membrane protein glycosylation by one-month treatment with a cafeteria diet.Non-enzymatic glycation and glycoxidation protein products in foods and diseases: an interconnected, complex scenario fully open to innovative proteomic studies.A new glycation product 'norpronyl-lysine,' and direct characterization of cross linking and other glycation adducts: NMR of model compounds and collagen.Pathways of the Maillard reaction under physiological conditions.Plasma Proteins Modified by Advanced Glycation End Products (AGEs) Reveal Site-specific Susceptibilities to Glycemic Control in Patients with Type 2 Diabetes.The combined effect of acetylation and glycation on the chaperone and anti-apoptotic functions of human α-crystallin.Maillard Proteomics: Opening New Pages.Probing Protein Glycation by Chromatography and Mass Spectrometry: Analysis of Glycation Adducts.Advanced glycation end products attenuate the function of tumor necrosis factor-like weak inducer of apoptosis to regulate the inflammatory response.Structural, biological and biophysical properties of glycated and glycoxidized phosphatidylethanolamines.Encapsulation of ascorbic acid promotes the reduction of Maillard reaction products in UHT milk.Site-specific analysis of advanced glycation end products in plasma proteins of type 2 diabetes mellitus patients.
P2860
Q30316666-4DF755D9-34A3-48C3-83C8-BCEAB4C091D2Q30317115-252DE945-412B-4FE2-9234-9FC183C4D909Q35152739-521608DF-090F-4948-8002-7231833A9D5DQ35669404-99DB734F-86CF-40F2-9564-EAFEBD35145CQ35882891-20BF28A6-8F16-4714-A7BE-7A6781A95205Q38151611-FBE72ACD-B848-459E-8C8F-330128805F91Q38271792-44C79F31-B07B-4232-8F80-9410B7D18938Q38862611-7C117A78-0BE0-436F-AA34-B78D7C984D30Q40789140-AF5D081D-E121-45E8-BFA5-9B22086ACA2EQ42174159-67AD31A2-78B3-41EF-9EAB-C4BFFA52DF6EQ47303198-36E03762-7E33-414F-92CF-C4AE014F96DFQ47340371-71EF11D2-4B71-45B6-B8CA-10838303E5F2Q50690444-86164EC9-E395-477D-9899-8597D166A097Q52878671-CFACE708-3D37-4443-B5D0-3AA5C2893381Q53603736-D26D335F-F654-4CC2-BB84-951109A2DCD1Q53752730-2C648557-3FB0-434E-A475-11B774F38E1A
P2860
Molecular basis of maillard amide-advanced glycation end product (AGE) formation in vivo
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Molecular basis of maillard amide-advanced glycation end product (AGE) formation in vivo
@ast
Molecular basis of maillard amide-advanced glycation end product (AGE) formation in vivo
@en
type
label
Molecular basis of maillard amide-advanced glycation end product (AGE) formation in vivo
@ast
Molecular basis of maillard amide-advanced glycation end product (AGE) formation in vivo
@en
prefLabel
Molecular basis of maillard amide-advanced glycation end product (AGE) formation in vivo
@ast
Molecular basis of maillard amide-advanced glycation end product (AGE) formation in vivo
@en
P2093
P2860
P356
P1476
Molecular basis of maillard amide-advanced glycation end product (AGE) formation in vivo
@en
P2093
Christian Henning
Christof Ulrich
Marcus A Glomb
Mareen Smuda
Matthias Girndt
P2860
P304
44350-44356
P356
10.1074/JBC.M111.282442
P407
P577
2011-11-08T00:00:00Z